Designing Clinical Trial Materials Patients Actually Understand

If Patients Cannot Understand a Study, They Cannot Meaningfully Consider Participating

Sponsors invest significant time and resources developing clinical trial materials.

Protocols are translated into brochures. Recruitment campaigns are launched. Websites are created. Educational materials are reviewed and approved. Informed consent documents are carefully drafted.

Yet despite these efforts, many patients still struggle to understand what participation actually involves.

The challenge is not a lack of information.

It is often too much information delivered in a way that prioritizes scientific accuracy over patient understanding.

Patients cannot make informed decisions if they are overwhelmed, confused, or uncertain about what a study entails. Likewise, recruitment campaigns cannot achieve their full potential if the materials supporting them fail to answer the questions patients are actually asking.

The most effective clinical trial materials are not simply accurate.

They are understandable.

Clinical Research Is Complex. Participant Communication Shouldn’t Be.

Clinical development teams work in a world filled with scientific terminology, regulatory requirements, and technical language.

Patients do not.

For many participants, a clinical trial may be their first direct exposure to clinical research. They may have limited familiarity with concepts such as randomization, inclusion criteria, endpoints, placebo controls, or study procedures.

When materials are written from the perspective of researchers instead of participants, they often become difficult to navigate.

Common challenges include:

• Medical jargon
• Lengthy explanations
• Dense text blocks
• Unclear processes
• Inconsistent terminology
• Vague next steps

While every individual piece of information may be technically accurate, the overall experience can still create confusion.

Patients who do not understand a study are less likely to participate. Those who do participate may enter with unrealistic expectations that can affect retention later.

Understanding should not be treated as a secondary objective.

It should be one of the primary goals of every patient-facing communication.

Patients Evaluate Studies Differently Than Sponsors

Sponsors often focus on explaining the science.

Patients often focus on understanding what participation will mean for their lives.

These perspectives are both important, but they are not the same.

Patients frequently want answers to questions such as:

• Why is this study being conducted?
• What will participation involve?
• How much time will this require?
• Will travel be necessary?
• What support is available?
• What happens if I decide to leave the study?
• How will this affect my family or caregiver?

Unfortunately, many recruitment materials answer these questions late in the process—or not at all.

Instead, they focus heavily on study design, eligibility criteria, or scientific objectives.

The most effective patient communications recognize that patients evaluate participation differently than study teams.

Good materials meet patients where they are rather than expecting patients to think like researchers.

Health Literacy Is a Recruitment Consideration

Health literacy is sometimes discussed as a communication issue.

In reality, it is also a recruitment issue.

Patients have varying levels of familiarity with medical terminology, healthcare systems, and clinical research concepts.

Materials that seem straightforward to clinical teams may feel highly technical to patients and caregivers.

Organizations that prioritize health literacy often focus on:

• Plain language
• Clear organization
• Logical flow
• Consistent terminology
• Readable formatting
• Action-oriented communication

The goal is not to oversimplify information.

The goal is to make important information easier to understand.

When patients understand what they are reading, they are more likely to engage, ask questions, and make informed decisions.

When they do not, uncertainty often becomes a participation barrier.

Clarity Builds Confidence

Patients are often asked to make significant decisions when considering clinical research participation.

Uncertainty can create hesitation.

Clarity can create confidence.

Well-designed clinical trial materials help participants understand:

• Expectations
• Responsibilities
• Potential benefits
• Potential risks
• Available support
• Participation logistics

They reduce ambiguity and provide practical information patients can use to evaluate whether participation is right for them.

This is particularly important in rare disease communities where families may already be navigating complex healthcare challenges.

Patients should not have to decode a study brochure, website, or educational resource to understand basic participation requirements.

The easier it is to understand a study, the easier it becomes for patients to evaluate participation confidently.

Visual Design Matters More Than Most Sponsors Realize

The effectiveness of clinical trial materials is influenced by more than words alone.

Presentation matters.

Even high-quality content can become difficult to absorb when it is presented poorly.

Patients are more likely to engage with materials that are:

• Well organized
• Easy to scan
• Visually accessible
• Structured logically

Many successful patient-facing resources use:

• Clear headings
• Subheadings
• Bullet points
• Visual timelines
• Icons and graphics
• Frequently asked questions

These elements help patients identify the information most relevant to them.

Good design does not replace good content.

It helps patients access and process it more effectively.

Patients Should Help Shape Patient Materials

One of the simplest ways to improve study communications is also one of the most overlooked.

Ask patients what they think.

Many sponsors invest substantial resources creating materials internally but never validate whether those materials actually resonate with patients.

Patient review can reveal:

• Confusing terminology
• Missing information
• Unanswered questions
• Unclear messaging
• Incorrect assumptions

These insights often help improve materials before recruitment begins.

Patient feedback does more than improve readability.

It helps ensure communications reflect the realities, concerns, and priorities of the people they are intended to serve.

The strongest patient materials are often developed with patients rather than simply for patients.

Better Materials Improve More Than Recruitment

Clinical trial materials are frequently viewed as recruitment tools.

Their impact extends much further.

Clear, patient-centered communication can also support:

• Participant confidence
• Study understanding
• Site interactions
• Ongoing engagement
• Retention

Patients who understand expectations from the beginning are often better prepared for the study experience.

They are less likely to feel surprised, confused, or frustrated as participation progresses.

This contributes to a stronger overall participant experience and may help reduce avoidable retention challenges.

Communication influences every stage of the participant journey.

Not just the beginning.

Conclusion

Every clinical trial depends on patients making informed decisions about participation.

That process becomes much more difficult when communications are confusing, overly technical, or disconnected from patient priorities.

Sponsors often focus on generating awareness, improving site performance, and increasing referrals. Those efforts matter. But many participation barriers can be traced back to a simpler issue: patients do not fully understand what they are being asked to consider.

Clear communication supports recruitment. It strengthens patient engagement. It helps create realistic expectations. And it contributes to a better participant experience throughout the study.

The most effective clinical trial materials do not simply communicate information.

They help patients understand it.

Understanding Creates Better Participation Decisions

Patient-centered communication is not just a content exercise. It is an important component of recruitment readiness and participant engagement.

PAS helps sponsors develop patient-friendly educational materials, recruitment resources, and engagement strategies that improve understanding, reduce participation barriers, and support better clinical trial experiences.